tao model (MedChemExpress)
Structured Review

Tao Model, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tao model/product/MedChemExpress
Average 93 stars, based on 3 article reviews
Images
1) Product Images from "Endothelial cell iron overload and ferroptosis mediate thrombosis and inflammation through the miR-32-5p/neurofibromin 2 pathway."
Article Title: Endothelial cell iron overload and ferroptosis mediate thrombosis and inflammation through the miR-32-5p/neurofibromin 2 pathway.
Journal: European journal of medical research
doi: 10.1186/s40001-025-02716-y
Figure Legend Snippet: Fig. 2 Ferroptosis was induced after the serum of the TAO patient’s treatment. a The cell viability of HUVEC cells after FBS, control serum, or TAO serum treatment (n = 5). b mRNA levels of key iron and ferroptosis-related markers after treatment with serum from control or TAO patients (n = 3). c Cell viability evaluated the capability of DFO and Fer1 after TAO serum treatment (n = 5). Protein levels of key iron, ferroptosis-related markers d, and NF2-YAP pathway e after treatment with serum from control or TAO patients (n = 3). f Then, the cellular iron and lipid peroxidation levels after serum treatment. *showed compassion between the control group and disease groups (n = 3). T test or one-way ANOVA, *: P < 0.05; **: P < 0.01, ***: P < 0.001, Error bar means SEM
Techniques Used: Control
Figure Legend Snippet: Fig. 3 A high level of exosomal miR-32-5p was involved in ferroptosis by binding to NF2. a, b Interaction of prediction between miR-32-5p and NF2. c The level of miR-32-5p in serum-derived exosomes from 15 controls and 15 TAO patients. d Luciferase activities of NF2 after miR-32-5p mimic transfection. e mRNA and f protein level of NF2 after miR-32-5p transfection (n = 3). g mRNA level of TFR1, ACSL4 after miR-32-5p transfection (n = 3). h Intracellular Fe2+ and lipid peroxidation levels in HUVEC cells after miR-32-5p transfection, DFO, or Fer1 treatment (n = 3). T test or one-way ANOVA, *showed compassion between the control group and the disease groups. *: P < 0.05; **: P < 0.01, ***: P < 0.001, Error bar means SEM
Techniques Used: Binding Assay, Derivative Assay, Luciferase, Transfection, Control
Figure Legend Snippet: Fig. 4 DFO and Fer1 improved clinical symptoms, inflammation, and thrombosis in the rat TAO model. a The schedule of rat TAO model introduction and treatments. DFO and Fer1 were treated from 7 days before sodium laurate injection to the endpoint of the model. b The curve of rat weight during the TAO process (n = 7). c The level of relative blood flow of the femoral arteries in different groups (n = 7). d The representative images of blood flow and tissue gangrene on the 14 th day after sodium laurate injection (n = 3). Then the tissues were evaluated by (E) HE (100 ×) and (F) Masson staining (100 ×) of femoral arteries in the rat TAO model, the black arrows showed infiltration of red cells and lymphocytes. n = 7. T test or one-way ANOVA, * showed compassion between the control group and the disease groups. *: P < 0.05; **: P < 0.01, ***: P < 0.001, Error bar means SEM
Techniques Used: Injection, Staining, Control
Figure Legend Snippet: Fig. 5 DFO and Fer1 balanced iron metabolism and inhibited ferroptosis in the rat TAO model. a Iron levels of femoral arterial lesions in the rat TAO model (n = 7). b The mRNA level of iron related genes in femoral arterial lesions of the rat TAO model (n = 7). c Perls’ stain (200 ×) in arterial tissues (n = 7). d The MDA level of femoral arteries among different groups (n = 7). e TEM images showed mitochondrial morphology in tissues (n = 3). Finally, the levels of f MDA and 4HNE were measured. n = 7. one-way ANOVA, * showed compassion between the control group and the disease groups. *: P < 0.05; **: P < 0.01, ***: P < 0.001, Error bar means SEM
Techniques Used: Staining, Control